Daily News Podcast

FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome


 

The FDA approved cannabidiol oral solution for the treatment of two rare pediatric seizure disorders. Also today, it’s a good idea to urge expectant parents to have a prenatal pediatrician visit, the Trump administration proposes changes to HHS and the FDA (view the complete proposal here), and after being approved for adults, the Eversense continuous glucose monitoring system is safe, durable, and accurate in children.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

Clostridium difficile Colitis in a Patient With Abdominal Distention, Pain, and Severe Constipation
Federal Practitioner
Type 2 diabetes may promote Parkinson development
Federal Practitioner
Epstein-Barr ‘Switches On” Autoimmune Genes
Federal Practitioner
Veterans Can Now Access Medical Images and Reports Online
Federal Practitioner
Autism Spectrum Disorders Are on the Rise
Federal Practitioner
Routine AAA screening for older men: more harm than good?
Federal Practitioner
TNF inhibitor linked to one-third drop in total mortality
Federal Practitioner
Testicular Pain Leads to a Rare Diagnosis
Federal Practitioner
Galectin-3: A post-MI prognostic biomarker for our times
Federal Practitioner
Patients going without as insulin prices skyrocket
Federal Practitioner